<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:PTGX (USA) Also Trade In: Germany

Protagonist Therapeutics Inc $ 12 0.41 (3.54%)

Volume:
74,599
Avg Vol (1m):
195,194
Market Cap $:
315.62 Mil
Enterprise Value $:
197.30 Mil
P/E (TTM):
0.00
P/B:
3.54
Warning! GuruFocus has detected 1 Severe warning sign with PTGX. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

5.2/10
Current Vs Industry Vs History
Cash-To-Debt 16.21
Equity-to-Asset 0.57
Debt-to-Equity 0.09
Debt-to-EBITDA -0.11
N/A
Piotroski F-Score 1
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.27
DISTRESS
GREY
SAFE
Beneish M-Score -7.06
Not Manipulator
Manipulator
WACC vs ROIC
ROIC 0%
WACC 13.16%

Profitability

1/10
Current Vs Industry Vs History
Operating Margin % -3848.78
Net Margin % -3578.33
ROE % -62.23
ROA % -46.64
ROC (Joel Greenblatt) % -1842.04
3-Year EBITDA Growth Rate 8.9
3-Year EPS without NRI Growth Rate 21.3

Ratios

Current Vs Industry Vs History
PB Ratio 3.54
PS Ratio 125.14
EV-to-EBIT -2.81
N/A
EV-to-EBITDA -2.84
N/A
EV-to-Revenue 107.21
Current Ratio 4.12
Quick Ratio 4.12

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -56.1

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 3.51
Price-to-Median-PS-Value 11.3
Earnings Yield (Greenblatt) % -35.89